250
Views
0
CrossRef citations to date
0
Altmetric
Review

Smartphone electrocardiogram monitoring: current perspectives

&
Pages 15-24 | Published online: 08 Jun 2018

References

  • Whitehead L, Seaton P. The effectiveness of self-management mobile phone and tablet apps in long-term condition management: A systematic review. J Med Internet Res. 2016;18(5):e97.
  • Pew Research Center. Mobile Fact Sheet; 2017. Available from: http://www.pewinternet.org/fact-sheet/mobile/. Accessed August 30, 2017.
  • Guzik P, Malik M. ECG by mobile technologies. J Electrocardiol. 2016;49(6):894–901.
  • Maurizi N, Faragli A, Imberti J, et al. Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®). Int J Cardiol. 2017;236:249–252.
  • N Maurizi, C Fumagalli, M Targetti, et al. 217 Comparative analysis of multiple leads smartphone electrocardiograph versus standard 12-leads electrocardiograph in patients with hypertrophic cardiomyopathy. EP Europace. 2018;20(suppl_1):i26.
  • Karijo E. Testing low-cost portable smartphone electrocardiographs in the screening of pregnant women in Mwingi West and Mwingi Central, Kitui County, Kenya; 2016. Available from: https://docs.wixstatic.com/ugd/5cb79f_27fe047906794f2dbe5a0c500defb369.pdf
  • Lim MCL, Lim I, Devaraj LM. Qualitative and quantitative accuracy of a novel multi-lead mobile phone ECG. Eur Heart J Suppl. 2010;12(suppl_A):S26.
  • Lim M, Lin Z, Michael L. ASSA13-07-1 Comparison of the ECG recordings using a novel mobile ECG recorder (EPI Mini) with a clinically validated mobile phone with ECG recording function (EPI Life). Presented at: Annual Scientific Sessions of APHA. Singapore; 2013. Available from: http://epimhealth.com/images/pdf/Abstract-ASSA13-07-1.pdf. Accessed January 16, 2018.
  • Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042–1046.
  • Borowsky LH, Regan S, Chang Y, Ayres A, Greenberg SM, Singer DE. First Diagnosis of Atrial Fibrillation at the Time of Stroke. Cerebrovasc Dis. 2017;43(3–4):192–199.
  • Hobbs FD, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005;9(40):iii–iv, ix–x, 1–74.
  • Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013;165(1):193–194.
  • Orchard J, Lowres N, Freedman SB, et al. Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): A feasibility study. Eur J Prev Cardiol. 2016;23(2 suppl):13–20.
  • Chan N-Y, Choy C-C. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram. Heart. 2017;103(1):24–31.
  • Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167–1175.
  • Treskes RW, Gielen W, Wermer MJ, et al. Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs for Atrial Fibrillation detection (MOBILE-AF): study protocol for a randomised controlled trial. Trials. 2017;18(1):402.
  • Hendrikx T, Rosenqvist M, Wester P, Sandström H, Hörnsten R. Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias. BMC Cardiovasc Disord. 2014;14:41.
  • Fetsch T, Bauer P, Engberding R, et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J. 2004;25(16):1385–1394.
  • Tarakji KG, Wazni OM, Callahan T, et al. Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study. Heart Rhythm. 2015;12(3):554–559.
  • January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–2104.
  • Chung EH, Guise KD. QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation. J Electrocardiol. 2015;48(1):8–9.
  • Garabelli P, Stavrakis S, Albert M, et al. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol. 2016;27(7):827–832.
  • Hickey KT, Hauser NR, Valente LE, et al. A single-center randomized, controlled trial investigating the efficacy of a mHealth ECG technology intervention to improve the detection of atrial fibrillation: the iHEART study protocol. BMC Cardiovasc Disord. 2016;16:152.
  • Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics-2016 Update: A Report from the American Heart Association. Circulation. 2016;133(4):e38–e360.
  • Muhlestein JB, Le V, Albert D, et al. Smartphone ECG for evaluation of STEMI: results of the ST LEUIS Pilot Study. J Electrocardiol. 2015;48(2):249–259.